Stock listing

Organon & Co.

Selected listing: 7XP · HAM · EUR · DE

Organon & Co. (Hamburg:7XP), Health Technology. Latest release Oct 1, 2026: Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%…

7XP:HAMEURDEUpdated October 2, 2026

Ticker: Hamburg:7XP
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Hamburg
Currency: EUR

Latest news from Organon & Co.

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

October 1, 2026

Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older

September 28, 2026

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

September 14, 2026

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability

August 11, 2026

Organon Announces Quarterly Dividend

July 31, 2026

All Organon & Co. news →

Events

Replays

Organon & Co. (OGN) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 08:30 AM ET
Watch
Organon & Co. (OGN) Q3 2025 Earnings Call
Mon, Nov 10, 2025 · 08:30 AM ET
Watch
Organon & Co. (OGN) Q2 2025 Earnings Call
Tue, Aug 05, 2025 · 08:30 AM ET
Watch

Research Organon & Co.

Organon & Co. company profile

View the public company page for Organon & Co. on 6ix.

Organon & Co. news

Read company news and market updates connected to Organon & Co..

Organon & Co. investor events

Find investor webinars, events, and replay context for Organon & Co..